SCPS
Scopus BioPharma Inc.
Set alert
0.00 USD 0.00 0.00%
0.0004 Day range 0.0004
0.0001 52-week range 0.01
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0004
- Prev close
- 0.0004
- Mkt cap
- 16.83K
- Vol
- 47.08K
- Avg vol
- 3.55K
- EPS
- -0.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0004
- High
- 0.0004
- Forward P/E
- -0.07
- Beta
- 1.16
- Short ratio
- 0.22
- Inst. own
- 2.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.1921
- 200-d avg
- 0.354155
- 1y target
- 12.00
Financial health
Altman Z-Score
-250.87 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.2×
FY 2017 5y median -17.1× FY 2022
P/S 0.0×
FY 2017 5y median 0.0× FY 2022
P/B -0.3×
FY 2017 5y median -108× FY 2022
P/FCF -0.3×
FY 2017 5y median -41.7× FY 2022
EV/EBITDA -0.2×
FY 2017 5y median -19.6× FY 2022
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2022
FCF Yield -393.2%
FY 2017 5y median -2.4% FY 2022
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2022
ROE 176.9%
FY 2017 5y median 631.7% FY 2022
ROIC 164.4%
FY 2017 5y median 164.4% FY 2022
ROA -2959.7%
FY 2017 5y median -517.2% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2022
Operating Income 57.6%
FY 2017 FY 2022
EPS (diluted) 65.8%
FY 2017 FY 2022
Free Cash Flow 28.9%
FY 2017 FY 2022
Financial Health
Current Ratio 0.1×
FY 2017 5y median 0.9× FY 2022
Quick Ratio 0.1×
FY 2017 5y median 0.9× FY 2022
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2022
Net Debt / EBITDA 0.0×
FY 2017 5y median 0.0× FY 2022
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31